Comparing two vs three cholesterol-lowering drugs after a heart attack
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study compares two approaches to lowering 'bad' cholesterol (LDL-C) in people hospitalized with acute coronary syndrome (a heart attack or unstable angina). One approach uses two medications (a statin plus another pill), and the other uses three (adding an injectable medicine). The goal is to see if the triple therapy lowers cholesterol more effectively and helps prevent future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be hospitalized with a recent heart attack or unstable angina (acute coronary syndrome).
- You must be able to take a high-intensity statin (a common cholesterol-lowering medicine) — your doctor can confirm.
- You must be willing to take study medications and attend follow-up visits.
- You cannot have severe liver or kidney disease, frequent gout attacks, or be allergic to the study drugs.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.
This trial tests a triple combination of medications (bempedoic acid, ezetimibe, and a high-intensity statin) in people who have never had a heart attack or stroke but have moderate to severe coronary artery disease. The goal is to see if this combination lowers cholesterol and reduces future heart risks more effectively than standard care.
This study tests whether a team-based program (including diet, exercise, and medication management) helps people who have had a heart event lower their 'bad' cholesterol (LDL) more effectively than standard care. It may help reduce your risk of future heart problems.
This study tests whether adding a medication called bempedoic acid to standard cholesterol-lowering pills is better at lowering cholesterol after a heart attack. If you have recently had a heart attack and are already on statins, this might be an option to help prevent future heart problems.
This study compares a new cholesterol medication combination to a standard high-intensity statin in patients aged 75 and older who have had a heart procedure to open blocked arteries. The goal is to see which treatment is better at managing cholesterol and reducing future heart risks.
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
Hear when a new Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.